Compound research hub
PT-141: Research, Handling and Batch Documentation
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide agonist at the MC3 and MC4 melanocortin receptors, and a metabolite of Melanotan II.
Part of Volta's melanotan peptides.
Identity and specification
- Form
- Lyophilized powder
- Appearance
- White to off-white lyophilised powder, typically supplied as the acetate salt
- Other known names
- Bremelanotide
- Compound class
- Melanocortin receptor agonist (MC3R / MC4R)
- Sequence, three-letter
- Phe-Arg-Trp-Lys
- CAS number
- 189691-06-3
- Molecular formula
- C₅₀H₆₈N₁₄O₁₀
- Molecular weight
- 1,025.2 g/mol
- PubChem CID
- 9941379
- Production
- Synthetic, by solid-phase peptide synthesis
- Solubility
- Soluble in sterile water
- Shelf life
- 24 months from date of manufacture
Molecular structure, sequence and the published laboratory studies on PT-141 are in the compound library entry for PT-141 (bremelanotide).
Vial sizes available
Every size of PT-141 Volta lists, in stock or not. Each is a separate catalogue page with its own batch number and specification table.
- Restocking
PT-141 10mg 10mgBatch #: VPPT10100
Purity and batch documentation
Volta's release specification is >99% (HPLC). That is a threshold we set. >99% is the specification every batch is released to. The figure on a certificate is what a laboratory measured for one lot.
No third-party certificate has been published for PT-141yet. The certificates Volta does publish, with the laboratory's own verification link on each, are in the certificate archive.
Research on PT-141
Comparisons
Handling and stability
Laboratory guides
Regulatory context
More melanotan peptides
PT-141 sits in Volta's melanotan peptides group, alongside the other compounds of the same composition. The whole range is on the full research catalogue, and the library of comparisons and guides is under peptide research.